Learn more about Evernorth Therapy Link, a new solution designed to identify and support patients who can benefit most from gene or cell therapies.

GLP-1 medications drive unprecedented growth in traditional drug spending, surpassing specialty drug trends for the first time.

Cancer rates are rising, yet early detection remains underused — despite its power to improve outcomes and reduce emotional strain.

Optimizing benefit communications can lead to better outcomes, fewer downstream costs and higher employee satisfaction.

As a dedicated rare disease partner, CuraScript SD helps ensure timely access to life-changing treatments.

The virtual care platform earned an “outstanding” ranking in the Telehealth and Treatment category.

Learn how health plans can help members get the right care – avoiding gaps, unnecessary treatments and added costs.